 |
|
|
| |
Lack of Pharmacokinetic (PK) Interaction Between Rilpivirine and the Integrase Inhibitors Dolutegravir and S/GSK1265744
|
| |
| |
Reported by Jules Levin
52nd ICAAC Sept 9-12 2012 SF
Susan L. Ford,1 Elizabeth Gould,1 Shuguang Chen,1 David Margolis,1 William Spreen,1 Herta Crauwels,2 Steve Piscitelli1
1GlaxoSmithKline, Research Triangle Park, NC, United States; 2Janssen R&D, Beerse, Belgium
|
| |
|
|
|
|
|
